Course Description
Investigator grant payments are the single greatest expense in a clinical trial, accounting for 40-60% of the total trial budget, and yet slow payments continue to be the most common complaint and challenge for sites. While the investigator payment process is quite challenging in the U.S. due to the multitude of compliance requirements and the approval process, the complexity multiplies exponentially in global trials. Challenges in the global environment are many and include but are not limited to working with multiple currencies and CRO’s, financial reporting across borders, contracting party issues, VAT taxes, and transparency compliance. This webinar will review the challenges inherent in the global trial payment process and outline opportunities to streamline, mitigate financial risk, and enable global standardization to your investigator grant spend.
Learning Objectives
Stuart Thiede is responsible for leading the highly skilled professionals who deliver investigator grant payment and tax services to clinical trial sponsors and CROs. Mr. Thiede joined CFS Clinical in 2009 and brings over 30 years’ experience from technology solution providers serving the pharmaceutical and other industries. Mr. Thiede’s diverse background includes significant executive roles in finance, operations, service delivery, and account management in enterprises ranging from start-ups to Fortune 500 technology companies. He also has significant international experience, including an expatriate assignment in Europe and a finance director role for a Latin American division of Unisys Corporation. Mr. Thiede has a B.S. in Accounting and an M.B.A. from Bowling Green State University in Bowling Green, Ohio.
Kevin Williams is responsible for driving the continued growth of the company through the marketing and strategic enhancement of the CFS solutions. Prior to this role at CFS, Kevin has been a leader from both a business development and operations perspective, responsible for the development, delivery, and growth of the investigator contract and grant payment services. He is focused on developing innovative, customer-focused solutions and efficient processes to address the needs of this critical area of clinical research. Kevin joined CFS in 2006 from Merck and has more than 15 years of experience in the Pharmaceutical and Healthcare Industries. Mr. Williams holds a B.S. in Health Science from Lock Haven University and an MBA/MS from Temple University (Fox School of Business) in Philadelphia, PA with a focus in Health Care Administration and Finance.
April Mulroney opened and works from the CFS UK office where she heads up the Global Payment Services group and is responsible for addressing international business, tax, and treasury issues for client’s global clinical trials. She also overseas accounts management for select European based clients. Previous to CFS, Ms. Mulroney served in a leadership role in the non-profit sector and with Deloitte & Touche, LLP, where she managed a vast portfolio of clients and provided consulting for their corporate tax compliance, planning and regulatory audits. Ms. Mulroney holds a certified public accountant designation (USA), chartered accountant designation (Canada), and a Bachelor’s of Commerce from the University of Toronto in Toronto, Ontario, Canada.
